Open AccessCoronavirus disease 2019 and neurodegenerative disease: what will the future bring?
Author(s) -
Lindsay McAlpine,
Arman Fesharaki-Zadeh,
Serena Spudich
Publication year - 2020
Publication title -
current opinion in psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.66
H-Index - 90
eISSN - 1473-6578
pISSN - 0951-7367
DOI - 10.1097/yco.0000000000000688
Subject(s) - disease , medicine , dementia , neuroinflammation , neurodegeneration , comorbidity , parkinson's disease , intensive care medicine , population , diabetes mellitus , psychiatry , environmental health , endocrinology
Over 70 million people worldwide, including those with neurodegenerative disease (NDD), have been diagnosed with coronavirus disease 2019 (COVID-19) to date. We review outcomes in patients with NDD and COVID-19 and discuss the hypothesis that due to putative commonalities of neuropathogenesis, COVID-19 may unmask or trigger NDD in vulnerable individuals.